Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuxi Jingyao Bio-Technology is a specialized life sciences company based in China that focuses on the research, development, and production of high-performance chromatography media and bioprocessing equipment. The company provides a comprehensive range of products including Protein A affinity resins, ion exchange resins, and hydrophobic interaction chromatography media essential for downstream processing. Their technology is primarily utilized in the purification of monoclonal antibodies, recombinant proteins, vaccines, and other biological therapeutics. In addition to consumables, Jingyao Bio-Technology offers automated chromatography systems and technical services to help biopharmaceutical manufacturers optimize their production workflows. By providing high-quality, localized alternatives to international bioprocessing brands, the company plays a significant role in the Chinese biopharma supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuxi Jingyao Bio-Technology.